Form D · Biotechnology
SalvaRx Group plc
Ramsey, Y8 · CIK 0001669673
Offering snapshot reported Mar 22, 2016 · SEC filing
- Reported sold
- $340K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 22, 2016 | Initial | $340,450 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259730
Source: Form D, filed Mar 22, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Armstrong | Director |
| Gregory Bailey | Director |
| James Mellon | Director |
| Kamlesh Shah | Director, Executive |
| Ian Walters | Director, Executive |
| Colin Weinberg | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Commerce House, 1 Bowring Road
Ramsey, Y8, IM8 2LQ
Ramsey, Y8, IM8 2LQ